Since severe COVID-19 is a manifestation of sepsis and involves these pro-inflammatory and coagulation pathways, annexin A5 is a viable treatment candidate (Singer et al., 2016; Mui et al., 2021). The gene discussed is ANXA5; the disease is COVID-19.